DRIO Profile
DarioHealth Corp., headquartered in New York, New York, is a prominent digital therapeutics company specializing in the development and provision of comprehensive health management solutions. Established in 2011 and rebranded from LabStyle Innovations Corp. to DarioHealth Corp. in July 2016, the company operates across multiple regions including the United States, Canada, the European Union, Australia, and New Zealand.
DarioHealth focuses on addressing a wide range of metabolic health needs through its diverse portfolio of digital solutions. The company's flagship offerings include Dario's Metabolic Solutions, which target chronic conditions such as diabetes, hypertension, and weight management. DarioMusculoskeletal is designed to prevent and treat common musculoskeletal (MSK) conditions, while Dario's Behavioral Health Solution enhances access to evidence-based mental health care. The company's Chronic Condition Management Solutions provide comprehensive support for ongoing health issues.
A key component of DarioHealth’s ecosystem is the DarioEngage platform, a proprietary care management tool that integrates various health monitoring technologies. This platform supports the use of smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, and biofeedback sensor devices. Additionally, DarioHealth offers device-specific disposables, such as test strip cartridges and lancets, to support blood glucose monitoring. Its diabetes management programs emphasize lifestyle modifications, healthy eating, advanced tracking, and live coaching to optimize patient outcomes.
Through its innovative approach and advanced technology solutions, DarioHealth aims to transform chronic disease management and personal health care. By leveraging digital tools and personalized care strategies, the company strives to improve patient engagement and health outcomes on a global scale, solidifying its position as a leader in the digital therapeutics industry.
|
